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Vegetal natural products (VNPs) have been the most successful sources of drugs in 
history. The development of High Throughput Screening (HTS) in the 80s generated a 
substantial shift towards plants extracts and VNPs in the Pharma Industry. This "Green 
Rush" terminated in the early 2000s when the Pharma companies stopped their HTS 
and bioprospecting programmes due to the intrinsic difficulties of this approach plus 
increasing costs and legal uncertainty to access genetic resources.  
Current drug discovery avenues include the bioprospection of marine organisms and 
microorganisms (which still have more “low hanging fruits” than VNPs), mining 
databases like DNP® with biochemoinformatics and artificial intelligence tools, 
repositioning “old” drugs from vegetal origin, as well as extensive pharmacological 
profiling of pure compounds. The development of Natural Fragment Libraries such as 
the NFL® developed at Pierre Fabre is also rather promising. 
Plants still have a bright future as Medicines despite the complexity of the recent 
Access and Benefit Sharing regulations. The use of standardized, purified extracts can 
bring effective public health solutions notably in developing country for a large part of 
pathologies. Their use in cosmetology is ever increasing. 
These aspects of the future of VNPs will be discussed from the perspective of our 30-
year industrial experience at Pierre Fabre (an international medium size Pharma and 
Dermocosmetics company, 13,000 employees worldwide which derives 40% of its 
turnover from plants). 
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